National Immunization
Programme in Sri Lanka
     Ruwandi De Silva
• 9 provinces & 26 districts
• Population 21,323,733 (2019)
• Life expec. at birth (75.3y)
      - Male 72.1y
      - Female 78.5y
• IMR-8/1000 live births (2018)
• <5Y mortality- 9/1000 live
  births (2018)
                 Vaccine
• Comes from Latin word “vaccinus” which
  means “pertaining to cows”
• The first vaccine was based on the
  relatively mild cowpox virus, which infected
  cows as well as people
History of Immunization &
       Vaccination
                Edward Jenner
                    (1749-1823)
          • English physician &
            scientist
          • The pioneer of the world's
            first vaccine -smallpox
            vaccine (1796)
        History of Immunization &
               Vaccination
• Edward Jenner, a country physician practicing in
  England, noticed that milkmaids rarely suffered from
  smallpox & often got cowpox. They never became
  ill with smallpox.
• In an experiment that laid the foundation for modern
  vaccines,
• Jenner took a few drops of fluid from a skin sore of a
  woman who had cowpox & injected the fluid into the
  arm of a healthy young boy who had never had
  cowpox or smallpox.
• Six weeks later, Jenner injected the boy with fluid from
  a smallpox sore, but the boy remained free of
  smallpox.
Vaccination
              Vaccination
• Vaccination is the administration of a vaccine
  to stimulate a protective immune response
  that will prevent disease in the vaccinated
  person if contact with the corresponding
  infectious agent occurs subsequently
• If the action is successful, it results in
  immunization
       vaccinated person has been immunized
• All vaccines produce antibodies which can
  neutralize extra cellular pathogens
• Live viral vaccines evoke response against
  intracellular pathogens ex. Measles vaccine
                Vaccination
• Vaccines are highly regulated, complex biologic
  products designed to induce a protective
  immune response both effectively and safely.
• One of the most important preventive health
  care interventions
• One of the most cost-effective health
  investments
• Today, there are many vaccines available to
  prevent nearly 30 communicable diseases
               Immunization
• Immunization aims to induce immunity
  against a disease
• Immunization is the process whereby a
  person is made immune or resistant to an
  infection, typically by the administration of   a
  vaccine
• Immunization is a proven tool for controlling
  and eliminating and eradicating life
  threatening infectious diseases
               Immunity
• The ability of the human body to tolerate
  the presence of material indigenous to the
  body (“self”), and to eliminate foreign
  (“non-self”) material
• This ability provides protection from
  infectious disease, since most microbes
  are identified as foreign by the immune
  system
• Immune system is classified into the
  innate immune system & the
  specific/acquired immune system
            Immunity Cont….
• Innate Imm. System consists of cells
       -monocytes, macrophages, dendritic cells,
neutrophils, eosinophils & natural killer cells
• Innate imm. System identifies pathogens &
  activates the specific/acquired imm. system
• Acquired Imm. System is composed of
  lymphocytes to produce antibodies &
  inflammatory cytokines
• Immunity to a microbe (antigen) is usually
  indicated by the presence of antibody to that
  organism
• Immunity is generally very specific to a single
  organism or group of closely related organisms
• There are two basic mechanisms for acquiring
  immunity - active and passive
           Active Immunity
• stimulation of the immune system to
  produce antigen-specific humoral
  (antibody) and cellular immunity
• usually lasts for many years, often for a
  lifetime
• Two ways to acquire active immunity
1. Through the survival after an infection
with the disease-causing form of the
organism. Ex….
• After the exposure of the immune system
  to an antigen, certain cells (memory B
  cells) continue to circulate in the blood
  (and also reside in the bone marrow) for
  many years. Upon re-exposure to the
  same antigen, these memory cells begin
  to replicate and produce antibody very
  rapidly to re-establish protection
2. Active immunity is by vaccination
• Vaccines interact with the immune system and
  often produce an immune response similar to
  that produced by the natural infection
• but they do not subject the recipient to the
  disease and its potential complications.
• Many vaccines also produce immunologic
  memory similar to that acquired by having the
  natural disease
            Passive Immunity
• The transfer of antibody produced by one human
  or other animal to another
• Passive immunity provides a temporary protection
  against some infections Bcz the antibodies will
  degrade over the time.
      Ex. most common form of passive immunity is
that which an infant receives from the mother.
      Antibodies are transported across the placenta
during the last 1–2 months of pregnancy.
      As a result, a full-term infant will have the
same antibodies as its mother.
      These antibodies will protect the infant from
certain diseases for up to one year.
      This type of protection is better against some
diseases
      Ex. measles,rubella & tetanus
  Factors may influence the
immune response to vaccination
• the presence of maternal antibody
• nature (live/non live) of antigen
• dose of antigen
• route of administration
• the presence of an adjuvant (e.g. aluminum/
  oil containing material) added to improve the
  immunogenicity of the vaccine
• Host factors such as age, nutritional factors,
  genetics & coexisting disease
    Development of Immunization
      Programmes in Sri Lanka
• 1886: Vaccination
  Ordinance : Compulsory
  vaccination for Smallpox –
  Date of commencement - 1st
  July 1887
• 1949 – BCG vaccine
• 1961 – Introduction of
  “Triple” vaccine/DPT
  (Diphtheria, Whooping
  Cough/Pertussis, Tetanus)
• 1962 – Oral polio vaccine
    Development of Immunization
      Programmes in Sri Lanka
• Responsible authority is Epidemiology Unit, MOH
• The Expanded Programme on Immunization (EPI)
  established in 1978
• 1984- Measles vaccine
• 1996-Rubella vaccine
      After 2000
• 2001 - MR vaccine
• 2003 - Hepatitis B vaccine
• 2008 - Hib (Haemophilus influenzae type B)
  containing Pentavalent vaccine (DPT, Hep B &
  Hib)
• 2009 - Live JE vaccine
• 2011 -MMR vaccine
• 2017 -HPV vaccine
     Reduction of vaccine
preventable diseases over time
   Direct achievements of National
      immunization programme
• Last case of Smallpox in Sri Lanka 1972 Globally
  Eradicated in 1979
• Last case of Diphtheria in 1991: almost eliminated
• Last case of Poliomyelitis in 1993 Regional Polio
  free certification 2014 and Global Eradication plan
  for 2016
• Congenital Rubella Syndrome: Near elimination
  stage
• Neonatal Tetanus last case in 2009 and
  eliminated
• South East Asia declared Maternal and neonatal
  tetanus elimination in 2016
National Immunization Policy in SL-
              2014
• To have a country free of vaccine preventable
  diseases
• To ensure the availability and affordability of quality
  immunization services
• To ensures the rational and evidence based
  introduction of new vaccines
• To ensure proper implementation by monitoring,
  evaluation, information management and operational
  research of immunization
• To ensure financial sustainability of the National
  Immunization Programme
• To ensure advocacy, promotion, awareness, protection
  and support for the Immunization Programmme
• To implement the national immunization policy in a
  systematic manner inclusive of all stakeholders
      Classification of vaccines
• Live attenuated
• Inactivated
        Live attenuated Vaccines
• Live vaccines are derived from “wild,” or
  disease-causing, virus or bacteria. These
• wild viruses or bacteria are attenuated, or
  weakened, in a laboratory, usually by
  repeated culturing. The resulting vaccine
  organism retains the ability to replicate (grow)
  in the vaccinated person and produce
  immunity, but usually does not cause illness.
• The immune response to a live attenuated
  vaccine is virtually identical to that produced
  by a natural infection.
        Live attenuated Vaccines
• Immunity following live vaccines is long-lasting,
  and booster doses are not necessary, with the
  exception of oral polio vaccine, which requires
  multiple doses.
• For live vaccines, the first dose usually provides
  protection
• The second dose is given to assure that nearly
  100% of persons are immune
• Currently available live attenuated viral vaccines
  include measles, mumps, rubella, varicella, yellow
  fever, oral polio and influenza (intranasal).
• Live attenuated bacterial vaccines include BCG
  and oral typhoid vaccine
          Inactivated vaccines
• produced by growing viruses or bacteria in
  culture media and then inactivating them with
  heat or chemicals (usually formalin)
• not alive
• they cannot grow in a vaccinated individual
  and therefore cannot cause the disease
  (even in an immunodeficient person)
• inactivated antigens are usually not affected
  by circulating antibody
• they are non-infectious but retain the ability
  to stimulate the immune system
          Inactivated vaccines
1. Whole cell vaccines
• Growing whole bacteria or viruses (e. g.
  inactivated influenza or inactivated polio
  vaccine) in culture media, then treating
  them with heat and/or chemicals,
  produces an inactivated, non-viable
  vaccine
            Inactivated vaccines
2. Toxoid vaccines
• In some bacterial infections (e.g. diphtheria,
  tetanus) the clinical manifestations of disease
  are caused not by the bacteria themselves but
  by the toxins they secrete.
• Toxoid vaccines are produced by purifying the
  toxin and altering it chemically
• While no longer toxic, the toxoid is still capable
  of inducing a specific immune response
  protective against the effects of the toxin
          Inactivated vaccines
3. Subunit vaccines
• The whole organism is grown in culture
  media and then the organism is further
  treated to purify only those components to
  be included in the vaccine
 e.g. acellular pertussis and the
meningococcal B vaccine)
          Inactivated vaccines
4. Recombinant vaccines
Example- Hepatitis B vaccine is made by
inserting a segment of the hepatitis B virus
gene into a yeast cell.
• The recombinant hepatitis B vaccine is
  identical to the natural hepatitis B surface
  antigen, but does not contain virus DNA
• Therefore unable to produce infection
            Inactivated vaccines
5. Conjugated vaccines
• Children under two years of age do not
  respond well to antigens such as
  polysaccharides, which produce antibodies
  via a T-cell independent mechanism
• If these polysaccharide antigens are
  chemically linked (conjugated) to a protein
  that T-cells recognize
• these conjugate vaccines can elicit strong
  immune responses & immune memory in
  young children
• Ex. Hib, HPV
• BCG- TB-Mycobaterium tuberculosis
• OPV- Poliomyelitis – Polio virus
• DTP- Diphtheria- Corynebacterium diphtheriae
       -Tetanus- Clostiridium tetani
       -Pertussis – Bordetella pertusis
• Hep B – Heapatitis B virus
• Hib –Bacterial meningitis - Haemophilus
  influenzae type B
• MMR- Measles- RNA virus
         - Mumps- RNA virus of Paramyxoviridae
family
         - Rubella- Toga virus
• JE-Japanese encephalitis – Flavi virus
              AEFI Form
Adverse Effect Following Immunization
AEFI Surveillance System in Sri
             Lanka
• SLMA Guidelines & Information on Vaccines
  2017
• https://slma.lk/wpcontent/uploads/2017/12/
  GSK-SLMA-Guidelines-Information-on-
  Vaccines.pdf